Sortiert nach Autor

Publikationen - sortiert nach Autor

• Rath J, Schober B, Zulehner G, Grisold A, Krenn M, Cetin H, Zimprich F (2021) Nerve conduction studies in Guillain-Barré syndrome: Influence of timing and value of repeated measurements J Neurol Sci, 420: 117267
• Rath J, Zulehner G, Schober B, Grisold A, Krenn M, Cetin H, Zimprich F (2021) Cerebrospinal fluid analysis in Guillain–Barré syndrome: value of albumin quotients J Neurol,

• Tomschik M, Hilger E, Rath J, Mayer E, Fahrner M, Cetin H, Löscher W, Zimprich F (2020) Subgroup stratification and outcome in recently diagnosed generalized myasthenia gravis Neurology, 95 (10): e1426-e1436
• Cetin H, Sun J, Almqvist C, Reichardt B, Tomschik M, Zimprich F, Fang F, Ingre C (2020) No association between proton pump inhibitor use and ALS risk: a nationwide nested case–control study Sci Rep, 10 (1)
• Cetin H, Webster R, Liu W, Nagaishi A, Koneczny I, Zimprich F, Maxwell S, Cossins J, Beeson D, Vincent A (2020) Myasthenia gravis AChR antibodies inhibit function of rapsyn-clustered AChRs J Neurol Neurosurg Psychiatry, 91 (5): 526-532
• Cetin H, Beeson D, Vincent A, Webster R (2020) The Structure, Function, and Physiology of the Fetal and Adult Acetylcholine Receptor in Muscle Front Mol Neurosci, 13
• Wurm R, Stamm T, Reichardt B, Schwarz F, Parvizi T, Silvaieh S, König T, Cetin H, Stögmann E (2020) Prescription patterns of antidementives in a high income country: A pharmacoepidemiologic study Alzheimer's Dement, 6 (1)
• Cetin H, Wurm R, Reichardt B, Tomschik M, Silvaieh S, Parvizi T, König T, Erber A, Schernhammer E, Stamm T, Stögmann E (2020) Increased risk of death associated with the use of proton‐pump inhibitors in patients with dementia and controls – a pharmacoepidemiological claims data analysis Eur J Neurol, 27 (8): 1422-1428
• Krenn M, Grisold A, Wohlfarth P, Rath J, Cetin H, Koneczny I, Zimprich F (2020) Pathomechanisms and Clinical Implications of Myasthenic Syndromes Exacerbated and Induced by Medical Treatments Front Mol Neurosci, 13

• Cetin H, Liu W, Cheung J, Cossins J, Vanhaesebrouck A, Maxwell S, Vincent A, Beeson D, Webster R (2019) Rapsyn facilitates recovery from desensitization in fetal and adult acetylcholine receptors expressed in a muscle cell line J. Physiol., 597 (14): 3713-3725
• Cetin H, Epstein M, Liu W, Maxwell S, Rodriguez Cruz P, Cossins J, Vincent A, Webster R, Biggin P, Beeson D (2019) Muscle acetylcholine receptor conversion into chloride conductance at positive potentials by a single mutation PNAS, 116 (42): 21228-21235
• Erber A, Cetin H, Berry D, Schernhammer E (2019) The role of gut microbiota, butyrate and proton pump inhibitors in amyotrophic lateral sclerosis: a systematic review Int J Neurosci, 130 (7): 727-735
• Krenn M, Tomschik M, Rath J, Cetin H, Grisold A, Zulehner G, Milenkovic I, Stogmann E, Zimprich A, Strom T, Meitinger T, Wagner M, Zimprich F (2019) Genotype‐guided diagnostic reassessment after exome sequencing in neuromuscular disorders: experiences with a two‐step approach Eur J Neurol, 27 (1): 51-61
• Rath J, Brunner I, Tomschik M, Zulehner G, Hilger E, Krenn M, Paul A, Cetin H, Zimprich F (2019) Frequency and clinical features of treatment-refractory myasthenia gravis J Neurol, 267 (4): 1004-1011

• Cetin H, Vincent A (2018) Pathogenic Mechanisms and Clinical Correlations in Autoimmune Myasthenic Syndromes Semin Neurol, 38 (03): 344-354
• Löscher W, Oberreiter E, Erdler M, Quasthoff S, Culea V, Berek K, Embacher N, Grinzinger S, Hess I, Höger F, Horlings C, Huemer M, Jecel J, Kleindienst W, Laich E, Müller P, Oel D, Örtl W, Lenzenweger E, Rath J, Stadler K, Stieglbauer K, Thaler-Wolf C, Wanschitz J, Zimprich F, Cetin H, Topakian R (2018) Multifocal motor neuropathy in Austria: a nationwide survey of clinical features and response to treatment J Neurol, 265 (12): 2834-2840

• Salhofer-Polanyi S, Cetin H, Leutmezer F, Baumgartner A, Blechinger S, Dal-Bianco A, Altmann P, Bajer-Kornek B, Rommer P, Guger M, Leitner-Bohn D, Reichardt B, Alasti F, Temsch W, Stamm T (2017) Epidemiology of Multiple Sclerosis in Austria Neuroepidemiol, 49 (1-2): 40-44
• Rath J, Mauritz M, Zulehner G, Hilger E, Cetin H, Kasprian G, Auff E, Zimprich F (2017) Iodinated contrast agents in patients with myasthenia gravis: a retrospective cohort study J Neurol, 264 (6): 1209-1217

• Cetin H, Wöhrer A, Rittelmeyer I, Gencik M, Zulehner G, Zimprich F, Ströbel T, Zimprich A (2016) The c.65-2A>G splice site mutation is associated with a mild phenotype in Danon disease due to the transcription of normal LAMP2 mRNA Clin Genet, 90 (4): 366-371

• Cetin H, Rath J, Füzi J, Reichardt B, Fülöp G, Koppi S, Erdler M, Ransmayr G, Weber J, Neumann K, Hagmann M, Löscher W, Auff E, Zimprich F (2015) Epidemiology of Amyotrophic Lateral Sclerosis and Effect of Riluzole on Disease Course Neuroepidemiol, 44 (1): 6-15
• Cetin H, Klickovic U, Rath J, Zulehner G, Füzi J, Reichardt B, Hagmann M, Wanschitz J, Löscher W, Auff E, Zimprich F (2015) Associations between co-medications and survival in ALS—a cohort study from Austria J Neurol, 262 (7): 1698-1705

• Zach H, Cetin H, Hilger E, Paul A, Wuschitz B, Jung R, Auff E, Zimprich F (2013) The effect of early prednisolone treatment on the generalization rate in ocular myasthenia gravis Eur J Neurol, 20(4): 708-13

• Cetin H, Fülöp G, Zach H, Auff E, Zimprich F (2012) Epidemiology of myasthenia gravis in Austria: rising prevalence in an ageing society Wiener Klinische Wochenschrift, 124 (21-22): 763-768